Every country in the world can afford to support its smokers to stop
2015-07-30
(Press-News.org) That is the conclusion of a major new review, written by leading world experts and published in the medical journal, Addiction. The review examined a wide range of measures that healthcare systems in different countries can adopt to help smokers to stop. It reviewed how effective they are and how much they cost, and offers a new tool to help governments and healthcare administrators calculate the cost - and affordability1 - of stop smoking treatments.
The main findings of the review were:
"Cytisine", a medicine currently only found in a few mostly Eastern European countries, and which has been shown to help smokers stop, would be affordable even in the world's poorest countries. It is safe and effective and all that is needed is for the medicines regulators to approve it.2
If all healthcare workers were trained to give brief advice to their patients on stopping smoking, as part of their everyday work, lasting no more than a few minutes, it could save thousands of lives at very little cost.
p>Tobacco smoking is estimated to kill about 6 million people each year worldwide and this number is rising. Tax increases, advertising bans, smoke-free laws and media campaigns play a crucial role in combating this epidemic. Supporting smokers to stop has so far received less attention in most countries, but is an important additional measure.
Professor Robert West, lead author of the report commented "The death and suffering caused worldwide by tobacco far outstrips anything that terrorists have been able to inflict. Many governments have started to introduce measures - such as increasing taxes and restricting smoking in public places - measures which make smokers want to stop. However few countries are actively supporting smokers to stop. Our report shows that every country in the world could be doing something. The more a country does, the more of their citizens' lives they will protect."
Professor Martin Raw, Director of the International Centre for Tobacco Cessation, and a key author of the report said "One of the barriers to countries doing more to offer support has been concern about cost. We highlight several approaches that can be introduced at very low cost, and offer governments a tool to help them select approaches."
INFORMATION:
1 A treatment is defined as 'affordable' for a country if the cost of saving a year of life was less than the average economic output of people in that country (per capita GDP).
2 The report shows that apart from cytisine and brief advice from a healthcare worker, telephone helplines, text messaging programmes, and books and booklets are effective and globally affordable.
ELSE PRESS RELEASES FROM THIS DATE:
2015-07-30
New research by scientists at the University of York has given tea and coffee drinkers new information about why their favourite drinks taste as they do.
The study led by Dr Seishi Shimizu, of the York Structural Biology Laboratory in the University's Department of Chemistry, shows that sugar has an important effect in reducing the bitterness of tea and coffee, not just by masking it but by influencing the fundamental chemistry.
The research published in Food and Function reveals new insights into the way in which caffeine, sugar and water interact at the molecular ...
2015-07-30
New research in the Open Access journal GigaScience presents a virtual package of data for biogas production, made reusable in a containerized form to allow scientists to better understand the production of biofuels.
One of the promising areas in biofuels development is biogas, which has huge potential as a renewable and clean source of energy. Biogas is the production of methane gas through the anaerobic digestion (fermentation) of organic matter such as agricultural or food waste. Detailed knowledge on the functioning of the fermentation process is key for optimizing ...
2015-07-30
A new blood test could help emergency room doctors quickly diagnose traumatic brain injury and determine its severity. The findings, published July 10 in the Journal of Neurotrauma, could help identify patients who might benefit from extra therapy or experimental treatments.
"Compared to other proteins that have been measured in traumatic brain injury, BDNF does a much better job of predicting outcomes," says Frederick Korley, M.D., Ph.D., an assistant professor of emergency medicine at the Johns Hopkins University School of Medicine and first author of the new paper.
After ...
2015-07-30
Philadelphia, July 30, 2015 - In a new national survey of chronic obstructive pulmonary disease (COPD) patients, Health Union reveals a surprising lack of awareness of risk factors and knowledge of diagnosis stage among patients. Results demonstrate a severe impact on quality of life, employment, and ability to afford treatment.
COPD, the third most common cause of death in the United States, describes a group of lung conditions that severely impact the breathing of nearly 15 million people in the U.S. (or six percent of the population) and more than 65 million worldwide. ...
2015-07-30
WASHINGTON, DC, July 28, 2015 -- Recent research has shown that racial segregation in the U.S. is declining between neighborhoods, but a new study indicates that segregation is manifesting itself in other ways -- not disappearing.
"We just can't get too excited by recent declines in neighborhood segregation," said lead author Daniel Lichter, the Ferris Family Professor in the Department of Policy Analysis and Management and a professor in the Department of Sociology at Cornell University. "The truth is neighborhood segregation still remains high in America, and our study ...
2015-07-30
This news release is available in French. By blocking the expression of a certain gene in patients, University of Montreal researchers have contributed to the demonstration of great decreases in the concentration of triglycerides in their blood, even in various severe forms of hypertriglyceridemia and regardless of the base values or the treatment the patient usually receives. The gene in question codes for the apoC-III protein. "Our study suggests that the proteine apoC-III plays a key role in the management of triglycerides. Triglycerides, like cholesterol, are lipids. ...
2015-07-30
URBANA, Ill. - With many types of cancers, early detection offers the best hope for survival. However, research into new early-detection screenings, as well as possible interventional radiology and surgical treatments, has been hindered by the lack of a large animal model that would accurately reflect the types of cancers seen in human cells.
For the last several years, researchers at the University of Illinois interested in improving screening programs for cancer have studied gene expression in mice, humans, and pigs in an effort to create a large-animal model that ...
2015-07-29
Support for eliminating existing exemptions, except for medical reasons, from immunization laws was among the policy recommendations adopted last weekend at the summer meeting of the Board of Regents of the American College of Physicians (ACP).
"Allowing exemptions based on non-medical reasons poses a risk both to the unvaccinated person and to public health," said Wayne J. Riley, MD, MPH, MBA, MACP, president of ACP,
"Intentionally unvaccinated individuals can pose a danger to the public, especially to individuals who cannot be vaccinated for medical reasons."
The ...
2015-07-29
A targeted therapy already used to treat advanced skin cancer is also effective against the most common subtype of the brain tumor medulloblastoma in adults and should be considered for treatment of newly diagnosed patients, according to research led by St. Jude Children's Research Hospital.
The drug, called vismodegib, is designed to block a key protein in the sonic hedgehog (SHH) signaling pathway. The pathway is normally active during fetal development and is inappropriately switched on in about 30 percent of medulloblastoma tumors, including about 60 percent of tumors ...
2015-07-29
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell. The engineered ribosome may enable the production of new drugs and next-generation biomaterials and lead to a better understanding of how ribosomes function.
The artificial ribosome, called Ribo-T, was created in the laboratories of Alexander Mankin, director of the UIC College of Pharmacy's Center for Biomolecular Sciences, ...
LAST 30 PRESS RELEASES:
[Press-News.org] Every country in the world can afford to support its smokers to stop
